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Abstract  
Recent studies have demonstrated that AMP-activated protein kinase (AMPK) in the hypothalamus 
is involved in the regulation of food intake. Because exercise is known to influence appetite and 
causes substrate depletion it may also influence AMPK in the hypothalamus. Male rats either 
rested or ran for 30 or 60 min on a treadmill (22m/min, 10% slope) and were sacrificed 
immediately after exercise or after 60 min recovery either in the fasted state or after oral gavage 
with glucose (3g/kg body weightbw). Exercise decreased muscle and liver glycogen substantially. 
Hypothalamic total or α2-associated AMPK activity and phosphorylation state of the AMPK 
substrate acetyl-CoA carboxylase (ACC) were not changed significantly immediately following 
treadmill running or during fed or fasted recovery. Plasma grehlin increased (p<0.05) by 40% 
during exercise whereas the concentration of PYY was unchanged. In recovery, glucose feeding 
increased plasma glucose and insulin concentrations whereas grehlin and PYY decreased to 
(grehlin) or below (PPY) resting levels. It is concluded that 1 h of strenuous exercise in rats does 
not elicit significant changes in hypothalamic AMPK activity despite an increase in plasma 
ghrelin. Thus, changes in energy metabolism during or after exercise are likely not coordinated by 
changes in hypothalamic AMPK activity. 
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Introduction 
AMP-activated protein kinase (AMPK) is the downstream component of a protein kinase 
cascade that plays a key role in regulating energy metabolism [1-3]. AMPK is activated by an 
increase in the AMP:ATP ratio within the cell, and in response phosphorylates a number of targets 
leading to a decrease in energy utilising pathways and an increase in energy producing pathways. 
A number of studies have shown that AMPK activity in skeletal muscle is increased following 
exercise in both humans and rodents [4-8]. Furthermore, activation of AMPK in resting skeletal 
muscle increases both glucose uptake and fatty acid oxidation [9] as well as gene expression [10; 
11], leading to speculation that AMPK could mediate the increase in these pathways in response to 
exercise {Winder, 1999 3011 /id format ref}. Recent studies, however, have indicated that genetic 
deletion of either the α1 or α2 catalytic subunits [12] or the γ3 regulatory subunit [13] of AMPK 
has no effect on contraction-stimulated glucose uptake in skeletal muscle and that AMPK is not 
required for the increase in GLUT4 expression in response to exercise [14]. The precise 
physiological significance of AMPK in mediating the effects of exercise on skeletal muscle 
metabolism therefore remains unclear. 
Recent studies have demonstrated that AMPK plays a role in the central regulation of energy 
metabolism. An exciting advance in the field was the finding that AMPK activity in the 
hypothalamus is altered by hormones that control feeding e.g. leptin and ghrelin [15; 16]. 
Furthermore, inhibition of hypothalamic AMPK leads to reduced food intake [16; 17], whereas 
activation increases food intake [15; 16]. Exercise leads to changes in appetite such that appetite is 
suppressed during strenuous exercise [18; 19] and a short while after exercise whereas increases in 
appetite after a single bout of exercise are inconsistent (For review see[19]). The mechanism 
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behind this exercise-induced change in appetite is not known [19] but could involve changes in 
hypothalamic AMPK activity which may serve the function of coordinating energy expenditure 
during exercise with energy intake during or after exercise. 
 
In this study we therefore have therefore investigated whether AMPK activity in the 
hypothalamus is affected during or after exercise and whether it is influenced by the nutritional 
status after exercise.  
  
Methods 
Experimental Animals 
All experiments were approved by the Danish Animal Experiments Inspectorate and complied 
with the Principles of Laboratory Animal Care (National Institutes of Health publication no. 85-
23, revised 1985). Fifty male Wistar rats weighing ~200 grams were subjected to three treadmill 
familiarisation sessions of 15 – 20 minutes duration per day leaving one rest day between 
familiarisation and the experimental day. The animals were divided into the following 5 groups 
consisting of rats that performed equally well on the treadmill. Group 1 acted as control group 
while groups 2 – 5 performed an exercise bout of varying duration. Group 2 ran for 30 minutes, 
group 3 ran for 60 minutes, group 4 ran for 60 minutes and rested for 60 minutes in the fasted 
condition, and group 5 ran for 60 minutes and rested for 60 minutes in the fed state. Immediately 
following the exercise bout, group 4 received a 1 ml oral gavage of 0.9 % saline solution while 
group 5 received 1 ml of saline containing 3.5 M glucose resulting in a glucose dose of 3g/kg. The 
night prior to the day of the experiment, rats were semi-fasted and received chow corresponding to 
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50% of their daily energy expenditure. On the day of the experiment, rats assigned to treadmill 
running ran at a speed of 22 m/min on a 10 degree incline. 
 
Collection of tissue and plasma samples 
Animals were sacrificed by decapitation. Trunk blood was collected together with dissection of the 
liver and soleus and the red and white part of the gastrocnemius muscle. Brains were immediately 
removed and the hypothalami block dissected and snap-frozen in liquid nitrogen. Plasma was 
separated by centrifugation, frozen and stored at -20°C until assay. 
 
Plasma assays 
Samples were assayed in duplicate.  Insulin in plasma was assayed using a commercial radio 
immuno-assay (RIA) using rat insulin as standard (Linco, St. Charles, USA). Ghrelin-like IR was 
measured with a specific and sensitive RIA as previously described [20]. The antibody used (SC-
10368 G102 Santa Cruz, CA, USA) recognises both octanoyl and des-octanoyl ghrelin and does 
not cross-react with any known gastrointestinal or pancreatic peptide hormones. PYY-like IR was 
measured using a specific and sensitive RIA, as previously described [21]. Glucose in plasma was 
measured by an ABL system 615 (Radiometer, Copenhagen, Denmark). Muscle and liver glycogen 
content were measured as glucose residues after acid hydrolysis [22]. 
 
AMPK assay 
Frozen tissues (approximately 50 mg) were homogenised in 0.2 ml ice-cold 50 mM Tris/HCl, pH 
7.5, 50 mM NaF, 5 mM Na pyrophosphate, 250 mM sucrose, 1 mM EDTA, 1 mM DTT, 1 mM 
benzamidine, 0.1% (w/v) phenylmethylsulphonylfluoride using an UltraTurax homogeniser (3 x 
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30 s bursts). Insoluble material was removed by centrifugation and the resulting supernatant used 
for immunoprecipitation of AMPK and Western blot analysis. Total AMPK was 
immunoprecipitated from 100 µg protein using an anti-pan β antibody [23] bound to protein A-
Sepharose and activity measured by phosphorylation of the SAMS synthetic peptide [24]. AMPK-
α2 specific activity was determined in immunoprecipitates isolated with an antibody specific for 
the α2 subunit [25].  
 
Western blot analysis 
Tissue lysates (40 µg) were resolved by SDS-PAGE and transferred to polyvinylidene fluoride 
membranes. ACC phosphorylation was measured with a phospho-ACC specific antibody (Upstate) 
and detected with an anti-rabbit antibody linked to horse radish peroxidase (Bio-Rad). Blots were 
developed using enhanced chemiluminescence (Pierce) and quantified using a 16-bit charged-
coupled device cooled camera and Gene Tools software (Syngene, Cambridge, UK). 
 
Statistical analysis 
All variables were analysed by ANOVA followed by post-hoc least significant difference tests.  
P<0.05 were taken to be significant 
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Results 
All of the exercise regimes employed in the study significantly reduced muscle and liver 
glycogen (Table 1). Administration of an oral glucose dose (3g/kg) following the 1h run resulted in 
a significant increase in tissue glycogen content in red gastrocnemius and liver relative to rats 
fasted during the 1h recovery period. Plasma glucose and insulin levels were not significantly 
changed by the exercise regime per se, although there was a trend towards decreased insulin levels 
following the exercise bout. In contrast, as would be predicted, there was a significant increase in 
both plasma glucose and insulin following the oral dose of glucose (Fig. 1A,B). 
Total hypothalamic AMPK activity, measured in immune complexes isolated following 
immunoprecipitation with a pan-β antibody that recognises both β1 and β2, was not changed by 
any of the exercise regimes (Fig. 2A). Since it has been reported previously that the predominant 
change in AMPK activity in the hypothalamus is associated with the α2 isoform we measured 
AMPK activity in immune complexes isolated with an α2-specific antibody (Fig. 2B). As with 
total AMPK activity there was no significant change in α2-associated activity. Consistent with the 
lack of effect of exercise on hypothalamic AMPK activity, there was no significant change in the 
phosphorylation state of ACC (Fig. 3).  
We have previously reported that AMPK activity in the hypothalamus is regulated by 
hormones that influence feeding: leptin inhibits, whereas ghrelin activates, AMPK [15]. The 
plasma level of ghrelin increased significantly following the 1h run, falling during the 1h recovery 
period. Administration of glucose during the recovery period resulted in the level of ghrelin 
returning to the control value (Fig. 4A). We were unable to accurately measure plasma leptin 
levels, which were very low in these animals (data not shown). Another hormone, that like leptin 
causes a decrease in food intake, is peptide YY 3-36 (PYY3-36) [26]. The concentration of plasma 
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PYY3-36 was not significantly altered immediately following exercise. During the 1h recovery 
period, however, the level of PYY3-36 was significantly reduced and this was not prevented by the 
oral glucose dose (Fig. 4B). 
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Discussion 
A number of recent studies have shown that AMPK plays a key role in regulating both energy 
intake and expenditure [1; 3]. In peripheral tissues, such as skeletal muscle, activation of AMPK 
switches on energy producing pathways and switches off  energy consuming pathways. In the 
hypothalamus, activation of AMPK leads to increased feeding, thereby increasing energy intake. 
Conversely, inhibition of AMPK in the hypothalamus reduces food intake. These dual functions of 
AMPK suggest that it may act to coordinate energy expenditure with energy intake. There is 
already some evidence that this may be the case in one situation. Leptin activates AMPK in 
skeletal muscle leading to increased fatty acid oxidation [27], whilst inhibiting AMPK in the 
hypothalamus leads to decreased food intake [16; 17]. We were interested to investigate whether 
exercise could affect AMPK activity in the hypothalamus, thereby providing a potential 
mechanism for the coordination of energy expenditure and energy intake during or following 
exercise. For instance, exercise leads to changes in appetite such that appetite is suppressed during 
strenuous exercise and a short while after exercise [18; 19] whereas increases in appetite after a 
single bout of exercise are not always found [19]). These changes in appetite could therefore be 
expected to stem from changes in hypothalamic AMPK activity. However, in this study we did not 
detect any change in hypothalamic AMPK activity in rats subjected to either 30 minutes or 1h 
treadmill running. Similarly, there was no change in hypothalamic AMPK activity after a 1h run 
followed by a 1h recovery period in which the rats were either fasted or given an oral glucose dose. 
Glycogen levels in muscle and liver were markedly reduced following exercise, indicating that the 
exercise regime was strenuous and created substrate depletion.  
ACC lies downstream of AMPK and we previously reported that ACC phosphorylation 
correlated with AMPK activity in the hypothalamus in response to treatment with either leptin or 
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ghrelin [15].  In the current study, however, we did not observe a change in the phosphorylation 
state of ACC in the hypothalamus, consistent with the lack of effect of exercise on AMPK activity 
in this tissue. However, it is possible that different intensities or durations of exercise, or different 
periods of recovery, could result in changes in hypothalamic AMPK activity. Future studies will 
have to determine this. 
 
Plasma ghrelin concentrations increased with exercise reaching significance after 60 min of 
running. In humans, exercise has been reported not to influence plasma ghrelin levels even at high 
exercise intensities [28-30]. We are unaware of other published data in which the plasma ghrelin 
response to exercise has been studied in rats. The reason for the increase of plasma ghrelin with 
exercise in the present study is not known but may indicate that the present exercise regime caused 
a larger depletion in substrate depots than in the human studies. In agreement with this assumption, 
plasma ghrelin concentrations only reached basal levels when recovery was accompanied by 
glucose feeding and partial restoration of liver and muscle glycogen stores. PYY is a 
gastrointestinal tract-derived hormone that is released post-prandially in proportion to the amount 
of calories ingested and leads to a reduction in food intake in rodents and man [26]. In contrast to 
the effect of exercise on plasma ghrelin concentration, the plasma concentration of PYY did not 
change during exercise but surprisingly decreased in recovery regardless of the feeding status of 
the rats. In humans the plasma concentration was also found not to change with exercise [31]. We 
have previously shown that injection of PYY, despite its actions on food intake, does not change 
AMPK activity in the rat hypothalamus [15]. 
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We reported previously that intraperitoneal injection of ghrelin to rats activates AMPK in the 
hypothalamus [15]. Plasma ghrelin concentration increased during 1h treadmill running, and this 
may have been expected to increase hypothalamic AMPK activity. However, although significant, 
the increase in ghrelin following exercise was small and presumably not sufficient to activate 
AMPK.  
 
In conclusion, although prolonged strenuous exercise in rats leads to increased plasma ghrelin 
concentrations it does not lead to changes in AMPK activity in the brain during or 1 hour after 
exercise regardless of the feeding status of the rats after exercise. Changes in appetite induced by 
exercise are thus unlikely to be due to alterations in hypothalamic AMPK activity and changes in 
energy metabolism during or after exercise are likely not coordinated by changes in hypothalamic 
AMPK activity. 
 
 
 
 
 
 
 
 
 
 
 
 
Hypothalamic AMPK and exercise; Andersson et al. 
12 
Reference List 
 
 [1] D.Carling, The AMP-activated protein kinase cascade--a unifying system for energy control 
Trends Biochem.Sci. 29, (2004) 18-24. 
 [2] D.G.Hardie, J.W.Scott, D.A.Pan, E.R.Hudson, Management of cellular energy by the AMP-
activated protein kinase system FEBS Lett. 546, (2003) 113-120. 
 [3] D.G.Hardie, D.Carling, M.Carlson, The AMP-activated/SNF1 protein kinase subfamily: 
metabolic sensors of the eukaryotic cell? Annu.Rev.Biochem. 67, (1998) 821-855. 
 [4] W.Derave, H.Ai, J.Ihlemann, L.A.Witters, S.Kristiansen, E.A.Richter, T.Ploug, Dissociation 
of AMP-activated protein kinase activation and glucose transport in contracting slow-
twitch muscle Diabetes 49, (2000) 1281-1287. 
 [5] T.Hayashi, M.F.Hirshman, E.J.Kurth, W.W.Winder, L.J.Goodyear, Evidence for 5`AMP-
activated protein kinase mediation of the effect of muscle contraction on glucose 
transport. Diabetes 47, (1998) 1369-1373. 
 [6] W.W.Winder, D.G.Hardie, Inactivation of acetyl-CoA carboxylase and activation of AMP-
activated protein kinase in muscle during exercise Am J Physiol 270, (1996) E299-
E304. 
 [7] J.F.Wojtaszewski, P.Nielsen, B.F.Hansen, E.A.Richter, B.Kiens, Isoform-specific and 
exercise intensity-dependent activation of 5'-AMP-activated protein kinase in human 
skeletal muscle J Physiol 528 Pt 1, (2000) 221-226. 
 [8] Z.P.Chen, G.K.McConell, B.J.Michell, R.J.Snow, B.J.Canny, B.E.Kemp, AMPK signaling in 
contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase 
phosphorylation Am.J.Physiol Endocrinol.Metab 279, (2000) E1202-E1206. 
 [9] G.F.Merrill, E.J.Kurth, D.G.Hardie, W.W.Winder, AICA riboside increases AMP-activated 
protein kinase, fatty acid oxidation, and glucose uptake in rat muscle Am J Physiol 
273, (1997) E1107-E1112. 
[10] B.F.Holmes, E.J.Kurth-Kraczek, W.W.Winder, Chronic activation of 5`-amp-activated protein 
kinase increases glut-4, hexokinase and glycogen in muscle., in: Anonymous, 1999, 
pp. 379A 
[11] W.W.Winder, B.F.Holmes, D.S.Rubink, E.B.Jensen, M.Chen, J.O.Holloszy, Activation of 
AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle J 
Appl.Physiol 88, (2000) 2219-2226. 
[12] S.B.Jørgensen, B.Viollet, F.Andreelli, C.Frøsig, J.Birk, P.Schjerling, S.Vaulont, E.A.Richter, 
J.F.Wojtaszewski, Knockout of the α2 but not α1 5´AMP-activated protein kinase 
isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribifuranoside but not 
Hypothalamic AMPK and exercise; Andersson et al. 
13 
contraction-induced glucose uptake in skeletal muscle J.Biol.Chem. 279, (2004) 1070-
1079. 
[13] B.R.Barnes, S.Marklund, T.L.Steiler, M.Walter, G.Hjalm, V.Amarger, M.Mahlapuu, Y.Leng, 
C.Johansson, D.Galuska, K.Lindgren, M.Abrink, D.Stapleton, J.R.Zierath, 
L.Andersson, The 5'-AMP-activated protein kinase gamma3 isoform has a key role in 
carbohydrate and lipid metabolism in glycolytic skeletal muscle J.Biol.Chem. 279, 
(2004) 38441-38447. 
[14] B.F.Holmes, D.B.Lang, M.J.Birnbaum, J.Mu, G.L.Dohm, AMP kinase is not required for the 
GLUT4 response to exercise and denervation in skeletal muscle Am.J.Physiol 
Endocrinol.Metab 287, (2004) E739-E743. 
[15] U.Andersson, K.Filipsson, C.R.Abbott, A.Woods, K.Smith, S.R.Bloom, D.Carling, C.J.Small, 
AMP-activated protein kinase plays a role in the control of food intake J.Biol.Chem. 
279, (2004) 12005-12008. 
[16] Y.Minokoshi, T.Alquier, N.Furukawa, Y.B.Kim, A.Lee, B.Xue, J.Mu, F.Foufelle, P.Ferre, 
M.J.Birnbaum, B.J.Stuck, B.B.Kahn, AMP-kinase regulates food intake by responding 
to hormonal and nutrient signals in the hypothalamus Nature 428, (2004) 569-574. 
[17] E.K.Kim, I.Miller, S.Aja, L.E.Landree, M.Pinn, J.McFadden, F.P.Kuhajda, T.H.Moran, 
G.V.Ronnett, C75, a fatty acid synthase inhibitor, reduces food intake via 
hypothalamic AMP-activated protein kinase J.Biol.Chem. 279, (2004) 19970-19976. 
[18] N.A.King, V.J.Burley, J.E.Blundell, Exercise-induced suppression of appetite: effects on food 
intake and implications for energy balance Eur.J.Clin.Nutr. 48, (1994) 715-724. 
[19] J.E.Blundell, R.J.Stubbs, D.A.Hughes, S.Whybrow, N.A.King, Cross talk between physical 
activity and appetite control: does physical activity stimulate appetite? Proc.Nutr.Soc. 
62, (2003) 651-661. 
[20] N.M.Martin, C.J.Small, A.Sajedi, M.Patterson, M.A.Ghatei, S.R.Bloom, Pre-obese and obese 
agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to 
ghrelin Int.J.Obes.Relat Metab Disord. 28, (2004) 886-893. 
[21] R.L.Batterham, M.A.Cohen, S.M.Ellis, C.W.Le Roux, D.J.Withers, G.S.Frost, M.A.Ghatei, 
S.R.Bloom, Inhibition of food intake in obese subjects by peptide YY3-36 
n.Engl.J.Med. 349, (2003) 941-948. 
[22] O.H.Lowry, J.V.Passonneau, A flexible system of enzymatic analysis, Academic, New York, 
1972 
[23] A.Woods, P.C.Cheung, F.C.Smith, M.D.Davison, J.Scott, R.K.Beri, D.Carling, 
Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly 
of the heterotrimeric complex in vitro J.Biol.Chem. 271, (1996) 10282-10290. 
Hypothalamic AMPK and exercise; Andersson et al. 
14 
[24] S.P.Davies, D.Carling, D.G.Hardie, Tissue distribution of the AMP-activated protein kinase, 
and lack of activation by cyclic-AMP-dependent protein kinase, studied using a 
specific and sensitive peptide assay Eur.J.Biochem. 186, (1989) 123-128. 
[25] A.Woods, I.Salt, J.Scott, D.G.Hardie, D.Carling, The alpha1 and alpha2 isoforms of the AMP-
activated protein kinase have similar activities in rat liver but exhibit differences in 
substrate specificity in vitro FEBS Lett. 397, (1996) 347-351. 
[26] R.L.Batterham, M.A.Cowley, C.J.Small, H.Herzog, M.A.Cohen, C.L.Dakin, A.M.Wren, 
A.E.Brynes, M.J.Low, M.A.Ghatei, R.D.Cone, S.R.Bloom, Gut hormone PYY(3-36) 
physiologically inhibits food intake Nature 418, (2002) 650-654. 
[27] Y.Minokoshi, Y.B.Kim, O.D.Peroni, L.G.Fryer, C.Muller, D.Carling, B.B.Kahn, Leptin 
stimulates fatty-acid oxidation by activating AMP-activated protein kinase Nature 415, 
(2002) 339-343. 
[28] R.Dall, J.Kanaley, T.K.Hansen, N.Moller, J.S.Christiansen, H.Hosoda, K.Kangawa, 
J.O.Jorgensen, Plasma ghrelin levels during exercise in healthy subjects and in growth 
hormone-deficient patients Eur.J.Endocrinol. 147, (2002) 65-70. 
[29] A.Schmidt, C.Maier, G.Schaller, P.Nowotny, M.Bayerle-Eder, B.Buranyi, A.Luger, M.Wolzt, 
Acute exercise has no effect on ghrelin plasma concentrations Horm.Metab Res. 36, 
(2004) 174-177. 
[30] R.R.Kraemer, R.J.Durand, E.O.Acevedo, L.G.Johnson, G.R.Kraemer, E.P.Hebert, 
V.D.Castracane, Rigorous running increases growth hormone and insulin-like growth 
factor-I without altering ghrelin Exp.Biol.Med.(Maywood.) 229, (2004) 240-246. 
[31] L.Saelsen, H.B.Andersen, P.Bratholm, N.J.Christensen, Radioimmunoassay of plasma 
neuropeptide Y using HPLC for separation of related peptides and fragments 
Scand.J.Clin.Lab Invest 54, (1994) 207-214. 
 
 
 
 
 
 
 
 
 
Hypothalamic AMPK and exercise; Andersson et al. 
15 
Acknowledgements 
This study was supported by grants from the Medical Research Council UK and the Wellcome 
Trust (to DC), the Copenhagen Muscle Research Centre and the Danish Medical Research 
Council. DC and EAR were jointly supported by an integrated project (contract LSHM-CT-2004-
005272) from the European Commission. JNN was supported by a postdoctoral fellowship from 
the Carlsberg Foundation 
 
Hypothalamic AMPK and exercise; Andersson et al. 
16 
Figure Legends 
 
Figure 1.  
Plasma glucose (A) and insulin (B) concentrations during and after exercise. Results shown are 
the mean ± S.E.M of 10 animals per group. Statistically significant changes compared to control 
groups are denoted * (p < 0.05).  
 
Figure 2.  Hypothalamic AMPK activity in response to exercise. 
Total AMPK activity (A) and AMPKα2-specific activity (B) were determined in immune 
complexes isolated from 100 µg lysate. Results are plotted as the percentage activity relative to 
the control group (non-exercised) and are the mean ± S.E.M of 10 aminals per group 
 
Figure 3.  Acetyl-CoA carboxylase (ACC) phosphorylation was determined by Western blotting 
using a phsopho-specific antibody. Blots were quantified and the results plotted as a percentage of 
the control group (A). Results shown are the mean ±S.E.M of 10 animals per 
group.  Α representative blot for each of the groups is shown in (B). Migration of theε α and β 
isoforms of ACC is indicated. 
 
Figure 4. Plasma levels of ghrelin  (A) and PYY3-36  (B) during and after exercise. 
Results shown are the mean ± S.E.M of 10 animals per group. Statistically significant changes 
compared to control groups are denoted * (p < 0.05) and between 1h run and 1h run followed by 
1h oral glucose administration by † (p < 0.05).   
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Tables. 
 
 
 
  Control 0.5h run 1h run 
1h run+ 
1h fast 
1h run+ 
1h glucose 
 Gastroc. muscle (white) 38±3 22±2* 22±2* 22±3* 26±3* 
 Gastroc. muscle (red) 36±2 19±2*† 15±2*† 19±1*† 26±3* 
Liver 91±13 53±9* 36±11* 25±4*† 60±6* 
 
 
Table 1. Muscle and liver glycogen content (µmol/g wet wt). Results are given as mean±S.E.M. of 
10 animals per group. *Ssignificantly from control (p<0.05). †Ssignificantly different from 1h 
run+1h glucose. 
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